ArticleCancer medicine2022

High-throughput membrane-anchored proteome screening reveals PIEZO1 as a promising antibody-drug target for human esophageal squamous cell carcinoma.

Xun Qin et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.